The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway.
Acta Pharmacol Sin. 2019 Oct;40(10):1292-1302. doi: 10.1038/s41401-019-0225-9. Epub 2019 Apr 23.
Acta Pharmacol Sin. 2019.
PMID: 31015738
Free PMC article.